Bonovas, S. ., Lytras, T. ., Nikolopoulos, G. ., Peyrin-Biroulet, L. ., & Danese, S. . (2018). Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors’ reply. Alimentary Pharmacology & Therapeutics, 47(4), 540-541. https://doi.org/10.1111/apt.14486